K

Krystal Biotech

Dermatology-focused topical gene therapies

Quality Assurance Associate

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeMoon Twp, PA, USANo salary listedIn-person

About the Job

Requirements

  • A minimum of a Bachelor's degree in Biology or a related Life Science.
  • At least 3 years of relevant quality systems experience in the biotechnology or pharmaceutical industry.
  • Knowledge or experience in Good Manufacturing Practices, Good Laboratory Practices, and Good Clinical Practice.
  • Strong knowledge of Good Manufacturing Practice and International Council for Harmonisation requirements.
  • Ability to work with minimal oversight and prioritize activities in a fast-paced, changing environment.

Responsibilities

  • Work with internal teams to understand the product and its documentation requirements.
  • Produce high-quality documentation that meets applicable standards and is appropriate for its intended use.
  • Develop expertise in FDA regulations and audit processes.
  • Initiate and update Good Manufacturing Practice manufacturing documentation, such as clearing procedures.
  • Provide oversight of daily Quality Assurance functions, including reviewing and approving records generated by manufacturing and quality control documents.
  • Support updates to standard operating procedures and associated forms.
  • Assist with site cGXP documentation related to gene therapy manufacturing operations.
  • Ensure compliance with regulatory agencies and oversee continuous improvement of the company's Quality Assurance and compliance functions.

Desired Qualifications

  • Experience with FDA audits is highly preferred.

About the Company

Krystal Biotech

Dermatology-focused topical gene therapies

Krystal Biotech develops and sells gene therapies for rare dermatological diseases. Its lead product, VYJUVEK (beremagene geperpavec-svdt), is a topical gene therapy designed to treat dystrophic epidermolysis bullosa (DEB) by delivering a corrected gene directly to the skin so that damaged skin can heal. The company’s STAR-D platform enables off-the-shelf gene therapies that can be used across a range of skin conditions and the VYJUVEK therapy is designed to be redoable, meaning its treatment can be repeated if needed. Krystal Biotech stands out by owning exclusive worldwide rights to its therapies and by being the first FDA-approved medicine for DEB, a rare condition. The company’s goal is to grow its portfolio of dermatology gene therapies using the STAR-D platform to provide accessible, repeatable treatments for patients with rare skin diseases.

Company size
201-500
Company stage
IPO
Headquarters
Pittsburgh, PA
Founded
2016

Recently Posted Jobs

Explore more opportunities at Krystal Biotech

See more jobs